Related Experiment Video
Updated: Jan 27, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
Adherence in Hypertension
Michel Burnier1, Brent M Egan2
1From the Service of Nephrology and Hypertension, Department of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (M.B.).
Insights
Poor adherence to hypertension medication is a major cause of uncontrolled blood pressure. Addressing patient adherence is crucial for managing hypertension effectively and reducing cardiovascular risks.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Hypertension is a leading global cause of noncommunicable disease deaths, largely uncontrolled worldwide.
- Suboptimal adherence to pharmacotherapy significantly contributes to poor blood pressure control in hypertensive patients.
- Adherence issues encompass failure to initiate, maintain, or persist with prescribed antihypertensive medications.
Purpose of the Study:
- To highlight the critical role of adherence in hypertension management.
- To identify factors contributing to medication nonadherence in hypertension.
- To emphasize the importance of addressing adherence in clinical practice and guidelines.
Main Methods:
- Review of factors associated with medication nonadherence in hypertension.
- Discussion of monitoring strategies for adherence in high-risk patients.
- Analysis of current approaches to improve adherence in hypertension management.
Main Results:
- Multiple factors (demographic, socioeconomic, medical, therapy-related, healthcare system, patient-specific) are linked to nonadherence.
- Electronic and biochemical monitoring can detect and improve adherence in high-risk individuals.
- Focusing on adherence is essential given the lack of new antihypertensive drugs.
Conclusions:
- Understanding adherence barriers is key to managing hypertension.
- Enhanced monitoring and accessibility of adherence measures offer future opportunities.
- Healthcare providers must prioritize drug adherence as a major component of hypertension management.
Abstract:
The global epidemic of hypertension is largely uncontrolled and hypertension remains the leading cause of noncommunicable disease deaths worldwide. Suboptimal adherence, which includes failure to initiate pharmacotherapy, to take medications as often as prescribed, and to persist on therapy long-term, is a well-recognized factor contributing to the poor control of blood pressure in hypertension. Several categories of factors including demographic, socioeconomic, concomitant medical-behavioral conditions, therapy-related, healthcare team and system-related factors, and patient factors are associated with nonadherence. Understanding the categories of factors contributing to nonadherence is useful in managing nonadherence. In patients at high risk for major adverse cardiovascular outcomes, electronic and biochemical monitoring are useful for detecting nonadherence and for improving adherence. Increasing the availability and affordability of these more precise measures of adherence represent a future opportunity to realize more of the proven benefits of evidence-based medications. In the absence of new antihypertensive drugs, it is important that healthcare providers focus their attention on how to do better with the drugs they have. This is the reason why recent guidelines have emphasize the important need to address drug adherence as a major issue in hypertension management.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Hypertension III: Clinical Manifestations and Diagnostic Studies

